Comments*

 
  • Academy Events

  • Frontiers in Cancer Immunotherapy

    February 27 - 28, 2017
    The New York Academy of Sciences

    Presented by The Mushett Family Foundation, Science, Science Immunology, Science Translational Medicine, and the New York Academy of Sciences

          SOLD OUT

    Cancer immunotherapy—the use of the immune system to treat cancer—is one of the most promising therapies to emerge since the development of chemotherapy in the mid-twentieth century. Harnessing the body's own innate defense mechanisms to attack cancer cells has demonstrated potential for developing treatments that are not only more efficacious (including long-lasting remissions and progression-free survival rates), but also more precise. Importantly, increased precision may reduce the toxicity that is often experienced with current pharmaceutical interventions. Different immunotherapeutic approaches, ranging from activating the patient's own immune response to attack cancer cells to neutralizing mechanisms designed to regulate and suppress patient's immune systems, are increasingly implemented in the regimen of oncology clinical care with positive results.

    This 2-day scientific symposium will explore emerging findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches in cancer treatment. The event will convene basic, preclinical, and clinical researchers active in the field of cancer immunotherapy, alongside industry representatives and government stakeholders. Dr. Padmanee Sharma, Professor of Genitourinary Medical Oncology and of Immunology at the University of Texas MD Anderson Cancer Center, will commence the conference with a Keynote Address. Plenary speakers will present on an array of topics, including: the evaluation of combination therapy strategies to improve clinical benefit; the development of immune-monitoring strategies for the identification of relevant prognostic and predictive biomarkers; the development of strategies to overcome immune tolerance; and the incorporation of genomics into immunotherapeutic research and clinical trials.

    Registration Pricing

      By 2/3/2017 After 2/3/2017 Onsite
    Member $175 $200 $250
    Student/Postdoc Member $150 $175 $225
    Nonmember (Academia) $250 $300 $375
    Nonmember (Corporate) $350 $400 $475
    Nonmember (Non-profit) $250 $300 $375
    Nonmember (Student/Postdoc/Fellow) $175 $200 $350

    Paid registration includes a complimentary, one-year membership to the New York Academy of Sciences. Complimentary memberships are provided to non-members only and cannot be used to renew or extend existing or expiring memberships. A welcome email will be sent upon registration which will include your membership credentials.

    On March 1, 2017, The New York Academy of Sciences' Cancer and Signaling Discussion Group will present a satellite symposium titled, Quantitative Approaches in Immuno-Oncology. This symposium will explore the emerging field of quantitative immuno-oncology, covering the breadth of scientific topics and methods needed to quantify interactions between tumors and the immune system.

    To learn more and register, visit www.nyas.org/QIO2017.


    Presented by

    • Mushett Family Foundation
    • Science
    • Science Immunology
    • Science Translational Medicine
    • The New York Academy of Sciences
    EmailPrint